Intercept Pharmaceuticals, Inc.
FARNESOID X RECEPTOR MODULATORS
Last updated:
Abstract:
The present application provides a compound of formula I: ##STR00001## or a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R.sup.1-R.sup.10, m, n, p, and are as described herein. The present invention relates generally to FXR modulators and to methods of making and using said compounds.
Status:
Application
Type:
Utility
Filling date:
14 May 2021
Issue date:
2 Sep 2021